Hunter Associates Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
12,636
+296
+2% +$39K 0.18% 112
2026
Q1
$1.72M Sell
12,340
-1,296
-10% -$181K 0.23% 101
2025
Q4
$1.67M Sell
13,636
-489
-3% -$59.4K 0.22% 103
2025
Q3
$1.57M Hold
14,125
0.22% 102
2025
Q2
$1.56M Sell
14,125
-2,200
-13% -$234K 0.23% 97
2025
Q1
$1.83M Sell
16,325
-1,400
-8% -$144K 0.28% 85
2024
Q4
$1.64M Sell
17,725
-200
-1% -$18K 0.25% 94
2024
Q3
$1.5M Buy
17,925
+200
+1% +$15.3K 0.23% 103
2024
Q2
$1.22M Sell
17,725
-500
-3% -$33.4K 0.2% 112
2024
Q1
$1.33M Sell
18,225
-200
-1% -$15.4K 0.22% 108
2023
Q4
$1.49M Hold
18,425
0.27% 94
2023
Q3
$1.38M Sell
18,425
-2,400
-12% -$185K 0.28% 86
2023
Q2
$1.6M Sell
20,825
-100
-0.5% -$7.97K 0.31% 71
2023
Q1
$1.74M Sell
20,925
-1,850
-8% -$153K 0.37% 64
2022
Q4
$1.96M Sell
22,775
-90
-0.4% -$7.13K 0.47% 55
2022
Q3
$1.41M Sell
22,865
-200
-0.9% -$12.6K 0.37% 68
2022
Q2
$1.43M Buy
23,065
+11,315
+96% +$701K 0.35% 70
2022
Q1
$699K Hold
11,750
0.23% 76
2021
Q4
$853K Sell
11,750
-8,250
-41% -$568K 0.24% 71
2021
Q3
$1.4M Hold
20,000
0.45% 47
2021
Q2
$1.38M Sell
20,000
-4,390
-18% -$293K 0.43% 45
2021
Q1
$1.58M Buy
24,390
+300
+1% +$19.3K 0.36% 63
2020
Q4
$1.4M Buy
24,090
+850
+4% +$51.3K 0.35% 64
2020
Q3
$1.47M Sell
23,240
-1,000
-4% -$69.3K 0.41% 58
2020
Q2
$1.86M Sell
24,240
-1,780
-7% -$136K 0.55% 46
2020
Q1
$1.95M Sell
26,020
-650
-2% -$44.9K 0.75% 32
2019
Q4
$1.73M Buy
26,670
+1,850
+7% +$120K 0.54% 46
2019
Q3
$1.57M Hold
24,820
0.54% 50
2019
Q2
$1.68M Buy
24,820
+1,400
+6% +$92.1K 0.58% 46
2019
Q1
$1.52M Sell
23,420
-150
-0.6% -$9.97K 0.53% 51
2018
Q4
$1.47M Buy
23,570
+250
+1% +$17.5K 0.6% 45
2018
Q3
$1.8M Sell
23,320
-14,256
-38% -$1.08M 0.62% 44
2018
Q2
$2.66M Sell
37,576
-1,349
-3% -$95.3K 0.96% 29
2018
Q1
$2.94M Sell
38,925
-2,610
-6% -$207K 1.1% 27
2017
Q4
$2.98M Sell
41,535
-4,250
-9% -$323K 1.1% 27
2017
Q3
$3.71M Sell
45,785
-1,940
-4% -$148K 1.45% 22
2017
Q2
$3.38M Sell
47,725
-4,663
-9% -$310K 1.37% 25
2017
Q1
$3.56M Buy
52,388
+3,170
+6% +$223K 1.5% 23
2016
Q4
$3.52M Sell
49,218
-85
-0.2% -$6.32K 1.5% 22
2016
Q3
$3.9M Buy
49,303
+9,655
+24% +$784K 1.68% 19
2016
Q2
$3.31M Buy
39,648
+7,013
+21% +$622K 1.43% 22
2016
Q1
$3M Buy
32,635
+2,287
+8% +$206K 1.37% 22
2015
Q4
$3.07M Sell
30,348
-625
-2% -$65K 1.35% 24
2015
Q3
$3.04M Sell
30,973
-1,075
-3% -$119K 1.43% 23
2015
Q2
$3.75M Buy
32,048
+1,813
+6% +$198K 1.56% 21
2015
Q1
$2.97M Buy
30,235
+4,415
+17% +$448K 1.17% 28
2014
Q4
$2.43M Buy
25,820
+5,245
+25% +$542K 0.94% 31
2014
Q3
$2.19M Sell
20,575
-1,650
-7% -$162K 0.85% 33
2014
Q2
$1.84M Buy
22,225
+525
+2% +$40.9K 0.72% 37
2014
Q1
$1.54M Buy
21,700
+400
+2% +$31.4K 0.61% 39
2013
Q4
$1.6M Buy
21,300
+50
+0.2% +$3.48K 0.62% 40
2013
Q3
$1.34M Sell
21,250
-400
-2% -$23.9K 0.56% 46
2013
Q2
$1.11M Buy
+21,650
New +$1.13M 0.41% 59

Other funds holding GILD

Hunter Associates Investment Management's GILD Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, buying an estimated $39K and bringing the position to 12,636 shares worth $1.6M. The position accounts for 0.18% of the portfolio, ranked #112.

Hunter Associates Investment Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.9M in Q3 2016. 1,065 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hunter Associates Investment Management held 12,636 shares of Gilead Sciences worth $1.6M as of Q2 2026.
  • Hunter Associates Investment Management bought 296 Gilead Sciences shares in Q2 2026, an estimated $39K.
  • Gilead Sciences made up 0.18% of Hunter Associates Investment Management's portfolio in Q2 2026, its #112 holding.
  • Hunter Associates Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Hunter Associates Investment Management's Gilead Sciences position peaked at $3.9M in Q3 2016.
  • 1,065 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.